Search
Now showing documents 1-1 of 1
The NOD-like receptors as endogenous inhibitors of multiple sclerosis
Other titre : Les récepteurs de type NOD en tant qu'inhibiteurs endogènes de la sclérose en plaques
(Université de Sherbrooke, 2019)
Abstract : Multiple sclerosis (MS) is a chronic disease of the CNS, manifested by relapses in the early phase followed by progressive disability in the later phase. Innate and adaptive immune responses play a critical role ...